Literature DB >> 2424405

The functions of oligosaccharide chains associated with influenza C viral glycoproteins. II. The role of carbohydrates in the antigenic properties of influenza C viral glycoproteins.

S Hongo, K Sugawara, M Homma, K Nakamura.   

Abstract

The antigenic properties of influenza C viral glycoprotein gp88 were compared with those of its nonglycosylated counterpart T76 synthesized in infected cells treated with tunicamycin. Radioimmunoprecipitation experiments with three different monoclonal antibodies against gp88 revealed that an antibody designated Q-5 precipitated gp88 but not T76, indicating the requirement for glycosylation for the binding of this antibody to gp88. It is unlikely, however, that the antigenic determinant recognized by Q-5 is carbohydrate moiety since the ability of the antibody to bind to gp88 varied depending on the virus strain, and trypsin-treatment of gp88 eliminated its reactivity with Q-5. Gel electrophoretic analysis under nonreducing conditions showed that T76 underwent the formation of disulfide-linked multimers in the absence of reducing agent while gp88 behaved as monomers, suggesting that glycosylation is required for gp88 molecules to attain an appropriate conformation. These observations, altogether, suggests that glycosylation is important in determining the immunological specificity of gp88 presumably by influencing the folding of this glycoprotein.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2424405     DOI: 10.1007/bf01309888

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  26 in total

1.  The nonglycosylated glycoprotein of vesicular stomatitis virus is temperature-sensitive and undergoes intracellular aggregation at elevated temperatures.

Authors:  R Gibson; S Schlesinger; S Kornfeld
Journal:  J Biol Chem       Date:  1979-05-10       Impact factor: 5.157

2.  The role of cytoplasmic membranes in poliovirus biosynthesis.

Authors:  L A Caliguiri; I Tamm
Journal:  Virology       Date:  1970-09       Impact factor: 3.616

3.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Carbohydrate-induced conformational changes of Semliki forest virus glycoproteins determine antigenicity.

Authors:  G Kaluza; R Rott; R T Schwarz
Journal:  Virology       Date:  1980-04-30       Impact factor: 3.616

6.  Effect of tunicamycin on the replication of Sendai virus.

Authors:  K Nakamura; M Homma; R W Compans
Journal:  Virology       Date:  1982-06       Impact factor: 3.616

7.  Effects of glucosamine, 2-deoxyglucose, and tunicamycin on glycosylation, sulfation, and assembly of influenza viral proteins.

Authors:  K Nakamura; R W Compans
Journal:  Virology       Date:  1978-02       Impact factor: 3.616

8.  Role of carbohydrates in protein secretion and turnover: effects of tunicamycin on the major cell surface glycoprotein of chick embryo fibroblasts.

Authors:  K Olden; R M Pratt; K M Yamada
Journal:  Cell       Date:  1978-03       Impact factor: 41.582

9.  The synthesis of polypeptides in influenza C virus-infected cells.

Authors:  M Yokota; K Nakamura; K Sugawara; M Homma
Journal:  Virology       Date:  1983-10-15       Impact factor: 3.616

10.  The functions of oligosaccharide chains associated with influenza C viral glycoproteins. I. The formation of influenza C virus particles in the absence of glycosylation.

Authors:  S Hongo; K Sugawara; M Homma; K Nakamura
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

View more
  9 in total

1.  Neutralization sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagated.

Authors:  L S Sawyer; M T Wrin; L Crawford-Miksza; B Potts; Y Wu; P A Weber; R D Alfonso; C V Hanson
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

2.  A comparison of T cell responses to glycoprotein B (gB-1) of herpes simplex virus type 1 and its non-glycosylated precursor protein, pgB-1.

Authors:  C A O'Donnell; W L Chan
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

3.  Antigenic and genetic analyses of eight influenza C strains isolated in various areas of Japan during 1985-9.

Authors:  S Ohyama; K Adachi; K Sugawara; S Hongo; H Nishimura; F Kitame; K Nakamura
Journal:  Epidemiol Infect       Date:  1992-04       Impact factor: 2.451

4.  The functions of oligosaccharide chains associated with influenza C viral glycoproteins. I. The formation of influenza C virus particles in the absence of glycosylation.

Authors:  S Hongo; K Sugawara; M Homma; K Nakamura
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

5.  Activity of influenza C virus O-acetylesterase with O-acetyl-containing compounds.

Authors:  A Garcia-Sastre; E Villar; J C Manuguerra; C Hannoun; J A Cabezas
Journal:  Biochem J       Date:  1991-01-15       Impact factor: 3.857

6.  Interactions of misfolded influenza virus hemagglutinin with binding protein (BiP).

Authors:  S M Hurtley; D G Bole; H Hoover-Litty; A Helenius; C S Copeland
Journal:  J Cell Biol       Date:  1989-06       Impact factor: 10.539

7.  Neutralizing Epitopes and Residues Mediating the Potential Antigenic Drift of the Hemagglutinin-Esterase Protein of Influenza C Virus.

Authors:  Yoko Matsuzaki; Kanetsu Sugawara; Yuki Furuse; Yoshitaka Shimotai; Seiji Hongo; Katsumi Mizuta; Hidekazu Nishimura
Journal:  Viruses       Date:  2018-08-09       Impact factor: 5.048

Review 8.  Hemagglutinin-esterase-fusion (HEF) protein of influenza C virus.

Authors:  Mingyang Wang; Michael Veit
Journal:  Protein Cell       Date:  2015-07-28       Impact factor: 14.870

Review 9.  Structure and function of the HEF glycoprotein of influenza C virus.

Authors:  G Herrler; H D Klenk
Journal:  Adv Virus Res       Date:  1991       Impact factor: 9.937

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.